CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


<
Plx Pharma Inc.  (PLXP)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Plx Pharma Inc.

PLXP's Financial Statements and Analysis






Plx Pharma Inc. increased II. Quarter net loss per share of $-0.41 compare to net loss per share of $-0.36 recorded in the same quarter a year ago a decrease from $0.57 eps realized in I. Quarter (Mar 31 2018).

Plx Pharma's Revenue fell by % in II. Quarter (Jun 30 2018) year on year, to $0 million and advanced by 105.58 % sequentially.


Plx Pharma is
More on PLXP's Income Statement

II. Quarter
Earnings Per Share Revenues
$ -0.41 $  0 Mill
$-0.05     Unch.     -55.46 %
You need to upgrade your Flash Player
PLXP's NET INCOME

Plx Pharma's in II. Quarter recorded net loss of $-4 million, an increase from net loss of $-2 million in II. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $4.98 million in previous quarter.

More on PLXP's Growth

In II. Quarter company's net cash and cash equivalents decreased by $-2 million, capital expenditures fell by 340.16%, to $-0 millions compare to same quarter a year ago and fell by 49.04% from I. Quarter (Mar 31 2018).

More on PLXP's Cash flow Statement



Plx Pharma Inc. does not pay out common stock dividend.

In trailing twelve-month period Plx Pharma Inc. payed $ -1.51 cash per share, on a free-cash flow basis .

Book value fell by -33.83 % sequentially to $0.75 per share.
Tangible Book value fell to $ 0.51 per share from $ 0.90.

Company issued 0.00 million shares or 0.06 % in II. Quarter.
Debt Coverage Ratio was 0.64.

More on PLXP's Dividends
 Market Capitalization (Millions) 37
 Shares Outstanding (Millions) 9
 Total Debt (Millions $) 7
 Revenue (TTM) (Millions $) -0
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -





Plx Pharma Inc. does not pay out common stock dividend.

In trailing twelve-month period Plx Pharma Inc. payed $ -1.51 cash per share, on a free-cash flow basis .

Book value fell by -33.83 % sequentially to $0.75 per share.
Tangible Book value fell to $ 0.51 per share from $ 0.90.

Company issued 0.00 million shares or 0.06 % in II. Quarter.
Debt Coverage Ratio was 0.64.

More on PLXP's Dividends
 Market Capitalization (Millions) 37
 Shares Outstanding (Millions) 9
 Total Debt (Millions $) 7
 Revenue (TTM) (Millions $) -0
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

REBL's Profile

Stock Price

REBL's Financials

Business Description

Fundamentals

Charts & Quotes

REBL's News

Suppliers

REBL's Competitors

Customers & Markets

Economic Indicators

REBL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071